ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

HRMY Harmony Biosciences Holdings Inc

31.69
1.42 (4.69%)
03 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Harmony Biosciences Holdings Inc HRMY 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
1.42 4.69% 31.69 08:51:22
개장가 저가 고가 종가 전일 종가
30.92 30.34 31.82 31.69 30.27
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
30/04/202420:05GLOBEHarmony Biosciences Reports Strong First Quarter Financial..
30/04/202420:00PRNUSHarmony Biosciences Acquires Epygenix Therapeutics, Inc.,..
16/04/202421:05PRNUSHARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL..
11/04/202421:05PRNUSHARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP..
03/04/202421:05PRNUSHARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL..
26/03/202421:05PRNUSHARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM..
12/03/202406:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202406:21EDGAR2Form 144 - Report of proposed sale of securities
29/02/202407:16EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
28/02/202422:05PRNUSHARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR..
23/02/202406:14EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/02/202422:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/02/202421:45EDGAR2Form 8-K - Current report
22/02/202421:30GLOBEHarmony Biosciences Reports Fourth Quarter and Full Year..
21/02/202422:05PRNUSU.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO..
20/02/202422:05PRNUSHARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG..
14/02/202409:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/02/202422:05PRNUSHARMONY BIOSCIENCES TO REPORT FOURTH QUARTER AND FULL YEAR..
27/01/202406:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/01/202406:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/01/202406:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/01/202406:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/01/202422:30EDGAR2Form 8-K - Current report
08/01/202422:05PRNUSHARMONY BIOSCIENCES PRELIMINARY UNAUDITED FOURTH QUARTER AND..
03/01/202422:05PRNUSHARMONY BIOSCIENCES TO PRESENT AT THE 42ND ANNUAL J.P...
08/12/202306:06EDGAR2Form 8-K/A - Current report: [Amend]
07/12/202322:05PRNUSHARMONY BIOSCIENCES ANNOUNCES POSITIVE TOPLINE DATA FROM..
05/12/202322:05PRNUSHARMONY BIOSCIENCES TO PRESENT RESULTS FROM BEHAVIORAL STUDY..
16/11/202322:05PRNUSHARMONY BIOSCIENCES TO PARTICIPATE IN PIPER SANDLER 35th..
15/11/202322:05PRNUSHARMONY BIOSCIENCES RANKED AMONG TOP 25 FASTEST-GROWING..
09/11/202306:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202323:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202322:59EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/11/202322:30EDGAR2Form 8-K - Current report
08/11/202322:05PRNUSHARMONY BIOSCIENCES APPOINTS PETER ANASTASIOU TO ITS BOARD..
31/10/202321:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202320:45EDGAR2Form 8-K - Current report
31/10/202320:30GLOBEHarmony Biosciences Reports Strong Third Quarter 2023..
26/10/202321:05PRNUSHARMONY BIOSCIENCES SHOWCASES THE NEWEST PATIENTS AT THE..
17/10/202321:05PRNUSHARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2023 FINANCIAL..
13/10/202321:15EDGAR2Form 8-K - Current report
13/10/202321:00PRNUSHARMONY BIOSCIENCES ANNOUNCES TOPLINE DATA FROM PHASE 3..
11/10/202321:15EDGAR2Form 8-K - Current report
11/10/202321:00PRNUSHARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA..
06/10/202305:15EDGAR2Form 8-K - Current report
05/10/202321:05PRNUSHARMONY BIOSCIENCES PRESENTS NEW SECONDARY OUTCOME DATA FROM..
04/10/202321:00EDGAR2Form 8-K - Current report
27/09/202321:00PRNUSHARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO..
25/09/202321:00EDGAR2Form 8-K - Current report
20/09/202321:05PRNUSHARMONY BIOSCIENCES PRESIDENT & CEO JEFFREY M. DAYNO, M.D.,..

최근 히스토리

Delayed Upgrade Clock